[go: up one dir, main page]

DK278379A - Mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazeptiner - Google Patents

Mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazeptiner

Info

Publication number
DK278379A
DK278379A DK278379A DK278379A DK278379A DK 278379 A DK278379 A DK 278379A DK 278379 A DK278379 A DK 278379A DK 278379 A DK278379 A DK 278379A DK 278379 A DK278379 A DK 278379A
Authority
DK
Denmark
Prior art keywords
benzazeptines
mercaptos
tetrahydro
substituted
Prior art date
Application number
DK278379A
Other languages
English (en)
Other versions
DK156001C (da
DK156001B (da
Inventor
K G Holden
C Kaiser
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of DK278379A publication Critical patent/DK278379A/da
Publication of DK156001B publication Critical patent/DK156001B/da
Application granted granted Critical
Publication of DK156001C publication Critical patent/DK156001C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK278379A 1978-07-07 1979-07-02 Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner DK156001C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92261378A 1978-07-07 1978-07-07
US92261378 1978-07-07

Publications (3)

Publication Number Publication Date
DK278379A true DK278379A (da) 1980-01-08
DK156001B DK156001B (da) 1989-06-12
DK156001C DK156001C (da) 1989-11-06

Family

ID=25447325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK278379A DK156001C (da) 1978-07-07 1979-07-02 Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner

Country Status (24)

Country Link
EP (2) EP0080012B1 (da)
JP (1) JPS5511584A (da)
AR (1) AR222828A1 (da)
AU (1) AU525789B2 (da)
CA (1) CA1115271A (da)
CS (1) CS213381B2 (da)
DD (1) DD147355A5 (da)
DE (1) DE2964530D1 (da)
DK (1) DK156001C (da)
ES (3) ES482282A1 (da)
FI (1) FI67215C (da)
GR (1) GR69675B (da)
HU (1) HU179315B (da)
IE (1) IE48654B1 (da)
IL (1) IL57532A (da)
IT (1) IT1193190B (da)
JO (1) JO1273B1 (da)
NO (1) NO152213C (da)
NZ (1) NZ190745A (da)
PH (1) PH15754A (da)
PL (1) PL216908A1 (da)
PT (1) PT69855A (da)
SU (1) SU1029827A3 (da)
ZA (1) ZA792785B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4652642A (en) * 1984-08-23 1987-03-24 Smithkline Beckman Corporation Azidobenzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists
US5942250A (en) * 1986-12-23 1999-08-24 Tristrata Technology, Inc. Compositions and methods for enhancing the topical effects of sunscreen agents
US6384079B1 (en) 1986-12-23 2002-05-07 Tristrata Technology, Incorporated Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
PL347237A1 (en) 1998-10-08 2002-03-25 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
JP2006504794A (ja) 2002-10-07 2006-02-09 グラクソ　グループ　リミテッド 抗精神病薬としてのスルホンアミド誘導体
EP2332921B1 (en) 2003-06-17 2016-03-02 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
JP4782003B2 (ja) 2003-06-17 2011-09-28 アリーナ ファーマシューティカルズ， インコーポレイテッド ５ｈｔ２ｃレセプター関連疾患の処置に有用なベンズアゼピン誘導体
JP4796047B2 (ja) * 2004-02-25 2011-10-19 イーライ リリー アンド カンパニー ５−ＨＴ２Ｃ受容体作用薬としての６−置換２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
NZ555981A (en) 2004-12-21 2011-01-28 Arena Pharm Inc Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
EP2111859A1 (en) 2004-12-23 2009-10-28 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
JP5404414B2 (ja) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ， インコーポレイテッド （ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンおよびその中間体を調製するための方法
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
CA2808909A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US20130315994A1 (en) 2010-09-01 2013-11-28 Zezhi Jesse Shao Modified-release dosage forms of 5-ht2c agonists useful for weight management
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストの非吸湿性塩
SG10201506896RA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management
CN116655892A (zh) * 2023-05-18 2023-08-29 常州大学 一种交联聚合物有机电极材料及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520264A (en) * 1947-08-26 1950-08-29 Maltbie Lab Inc Substituted 3, 1-benz-2, 3, 4, 5-tetrahydroazepines
US3483185A (en) 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
US3671519A (en) * 1969-07-14 1972-06-20 American Home Prod N-substituted 2,3,4,5,-tetrahydro-1h-3-benzazepines
US3752892A (en) 1970-03-11 1973-08-14 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepine derivative method and composition thereof
US3716639A (en) 1970-03-11 1973-02-13 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepines
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4108989A (en) * 1977-04-01 1978-08-22 Smithkline Corporation 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones

Also Published As

Publication number Publication date
GR69675B (da) 1982-07-07
JPS5511584A (en) 1980-01-26
JPH0153271B2 (da) 1989-11-13
ES482281A1 (es) 1980-04-01
DK156001C (da) 1989-11-06
NO152213C (no) 1985-08-28
FI67215C (fi) 1985-02-11
CS213381B2 (en) 1982-04-09
DE2964530D1 (en) 1983-02-24
AR222828A1 (es) 1981-06-30
DD147355A5 (de) 1981-04-01
FI792125A7 (fi) 1980-01-08
AU525789B2 (en) 1982-12-02
ES482276A1 (es) 1980-04-01
JO1273B1 (en) 1986-11-30
SU1029827A3 (ru) 1983-07-15
EP0007070A1 (en) 1980-01-23
EP0080012B1 (en) 1986-04-09
IT7924165A0 (it) 1979-07-06
IE48654B1 (en) 1985-04-03
NO792267L (no) 1980-01-08
IE791276L (en) 1980-01-07
ES482282A1 (es) 1980-04-01
EP0080012A1 (en) 1983-06-01
DK156001B (da) 1989-06-12
EP0007070B1 (en) 1983-01-19
IT1193190B (it) 1988-06-02
NO152213B (no) 1985-05-13
FI67215B (fi) 1984-10-31
IL57532A0 (en) 1979-10-31
PL216908A1 (da) 1980-08-11
ZA792785B (en) 1980-08-27
CA1115271A (en) 1981-12-29
PT69855A (en) 1979-08-01
AU4861379A (en) 1980-02-07
HU179315B (en) 1982-09-28
NZ190745A (en) 1981-01-23
IL57532A (en) 1982-08-31
PH15754A (en) 1983-03-18

Similar Documents

Publication Publication Date Title
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
NL7903029A (nl) 2'deoxy-5-(2-halogeenvinyl)-uridines.
DK537780A (da) 1,8-naphthyridin-derivater
NO153847C (no) 2,4,4-triklor-4-formyl-butyronitril.
FI792769A7 (fi) 3,4,5-trihydroxipiperidinderivat
FI793663A7 (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
SE7803411L (sv) 2,6-dialkoxibensamider
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
TR20548A (tr) 1,2,3-tiyadiyazel-5-yil uerelerin imalline mahsus usul
FI803727L (fi) 2,3-indolidionderivat
DK429179A (da) 2-propyl-pent-4-en-1-al.
ATA457479A (de) Stabilisietes 1,1,1-trichloraethan
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
ATA457579A (de) Stabilisiertes 1,1,1-trichloraethan
FI801473A7 (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
NL7900005A (nl) 11-alkanoyl-4"-desoxy-4"-isonitrilo-oleandomycine-deri- vaten.
BE883295A (fr) 6,7-secoergolines
FI792770A7 (fi) Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-ylkarbamider
FI793526A7 (fi) Foerfarande foer framstaellning av 5-merkapto-1,2,3-triazoler
DK136379A (da) 4,6-dihalogensteroider
FI792436A7 (fi) Foerfarande foer tillverkning av 7,8-diklortetrahydroisokinolin
DK430479A (da) 2,6-dihalogenbensylestere
AT370071B (de) Stabilisiertes 1,1,1-trichloraethan

Legal Events

Date Code Title Description
PBP Patent lapsed